QI
BHC icon

QS Investors’s Bausch Health BHC Stock Holding History

QS Investors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26,867
Closed -$491K – 1217
2020
Q2 		$491K Sell
26,867
-32,532
-55% -$573K 0.01% 905
2020
Q1 		$921K Sell
59,399
-7,300
-11% -$176K 0.01% 683
2019
Q4 		$2M Sell
66,699
-3,664
-5% -$95.3K 0.02% 589
2019
Q3 		$1.54M Buy
70,363
+36,496
+108% +$835K 0.02% 649
2019
Q2 		$854K Buy
+33,867
New +$804K 0.01% 839
2019
Q1 		– Sell
-6,500
Closed -$120K – 1665
2018
Q4 		$120K Buy
+6,500
New +$155K ﹤0.01% 1276
2018
Q3 		– Sell
-13,700
Closed -$318K – 1915
2018
Q2 		$318K Hold
13,700
– – ﹤0.01% 1060
2018
Q1 		$218K Buy
+13,700
New +$255K ﹤0.01% 1143
2017
Q2 		– Sell
-48,470
Closed -$535K – 1989
2017
Q1 		$535K Buy
48,470
+8,000
+20% +$110K ﹤0.01% 950
2016
Q4 		$588K Sell
40,470
-19
-0% -$349 ﹤0.01% 857
2016
Q3 		$994K Sell
40,489
-45,300
-53% -$1.17M 0.01% 778
2016
Q2 		$1.73M Buy
85,789
+3,316
+4% +$93.9K 0.01% 669
2016
Q1 		$2.17M Buy
82,473
+25,500
+45% +$1.89M 0.02% 625
2015
Q4 		$5.79M Buy
56,973
+7,189
+14% +$808K 0.06% 333
2015
Q3 		$8.88M Sell
49,784
-1,600
-3% -$373K 0.09% 202
2015
Q2 		$11.4M Sell
51,384
-9,990
-16% -$2.21M 0.14% 167
2015
Q1 		$15.4M Sell
61,374
-8,210
-12% -$1.46M 0.17% 132
2014
Q4 		$11.6M Buy
69,584
+27,908
+67% +$3.75M 0.13% 175
2014
Q3 		$5.47M Sell
41,676
-3,800
-8% -$453K 0.15% 142
2014
Q2 		$5.74M Buy
45,476
+11,200
+33% +$1.43M 0.15% 151
2014
Q1 		$4.99M Sell
34,276
-3,100
-8% -$424K 0.15% 154
2013
Q4 		$4.66M Buy
37,376
+5,500
+17% +$603K 0.18% 123
2013
Q3 		$3.42M Sell
31,876
-43,824
-58% -$4.27M 0.15% 152
2013
Q2 		$6.58M Buy
+75,700
New +$5.97M 0.23% 131

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

QS Investors's BHC Position: Q3 2020 in Review

QS Investors sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 26,867 shares — an estimated $491K sold.

QS Investors first reported a position in BHC in Q2 2013 and held it in 24 quarters. The position peaked at $15.4M in Q1 2015. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

  • QS Investors reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 26,867 Bausch Health shares in Q3 2020, an estimated $491K.
  • QS Investors first reported a position in Bausch Health in Q2 2013 and held it in 24 quarters.
  • QS Investors's Bausch Health position peaked at $15.4M in Q1 2015.
  • 324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.